August 3, 2010 --
San Diego -- Volcano Corporation (Nasdaq: VOLC),
a leading developer and manufacturer of precision intravascular
therapy guidance tools designed to enhance the diagnosis
and treatment of coronary and peripheral vascular disease,
said today that it will be participating in the 30th Annual
Canaccord Genuity Growth Conference on Tuesday, August
10.
The presentation by Scott Huennekens, president and chief
executive officer, will begin at 9 a.m., Eastern Daylight
Time (6 a.m., Pacific Daylight Time).
|